# FDA Inspection 1304664 - GlaxoSmithKline Biologicals SA - February 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/a737c389-4e6a-4fcc-94cb-27544c5ade52
Source feed: FDA_Inspections

> FDA Inspection 1304664 for GlaxoSmithKline Biologicals SA on February 27, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304664
- Company Name: GlaxoSmithKline Biologicals SA
- Inspection Date: 2026-02-27
- Product Type: Biologics
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1215345 - 2023-06-23](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/f7edf2ba-9037-4e72-9ab4-12d46616e90c)
- [FDA Inspection 1007184 - 2017-01-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/70cb7ce5-0715-4ec4-8b61-c997bb03b824)
- [FDA Inspection 900625 - 2014-10-02](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/9e518157-9df1-4b38-9fdf-fe6d1dfe4269)
- [FDA Inspection 818683 - 2012-10-05](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/b6c161d8-1307-454f-8246-b21976212187)
- [FDA Inspection 672159 - 2010-06-03](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/4295eb06-bce8-47d9-b105-1abe6654554a)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/ef569005-49c7-4bf9-b3f1-7814705bec8e

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8